Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain Neoplasms, Primary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00053118
What this trial is testing

Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer

Who this might be right for
Brain and Central Nervous System TumorsLymphomaNeuroblastoma+1 more
Roswell Park Cancer Institute 1
Large-scale testing (Phase 3)Active Not RecruitingNCT04939597
What this trial is testing

See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor

Who this might be right for
Central Nervous System Carcinoma
Children's Oncology Group 162
Early research (Phase 1)WithdrawnNCT03990597
What this trial is testing

StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord

Who this might be right for
Central Nervous System SarcomaEpendymomaGlioma+4 more
M.D. Anderson Cancer Center
Very early researchWithdrawnNCT04776980
What this trial is testing

Multimodality MRI and Liquid Biopsy in GBM

Who this might be right for
Glioblastoma MultiformeBrain Tumor, Adult: GlioblastomaBrain Tumor, Recurrent+1 more
Abramson Cancer Center at Penn Medicine
Not applicableStudy completedNCT04607460
What this trial is testing

EMG Biofeedback Treatment for Chronic Low Back Pain, Cancer Pain and Migraines

Who this might be right for
Chronic Low-back PainMastectomyLumpectomy+1 more
Brigham and Women's Hospital 330
Very early researchStudy completedNCT00452868
What this trial is testing

Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain

Who this might be right for
Brain and Central Nervous System TumorsCognitive/Functional EffectsLong-term Effects Secondary to Cancer Therapy in Children+3 more
Wake Forest University Health Sciences 14
Testing effectiveness (Phase 2)Study completedNCT01242566
What this trial is testing

Temozolomide in Elderly Patients With KPS < 70

Who this might be right for
Primary Brain TumorGlioblastoma
Assistance Publique - Hôpitaux de Paris 70
Testing effectiveness (Phase 2)Looking for participantsNCT07130786
What this trial is testing

Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

Who this might be right for
SeizuresPrimary Motor CortexBrain Metastases From Non-small Cell Lung Cancer (NSCLC)+2 more
Ayal A. Aizer, MD 150
Testing effectiveness (Phase 2)Study completedNCT04116138
What this trial is testing

Antisecretory Factor in Primary Glioblastoma 1

Who this might be right for
GlioblastomaCerebral EdemaChemotherapy Effect
Peter Siesjö 8
Early research (Phase 1)Study completedNCT00027625
What this trial is testing

Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Ended earlyNCT00003476
What this trial is testing

Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors

Who this might be right for
Childhood Brain Tumor
Burzynski Research Institute 8
Not applicableLooking for participantsNCT07426848
What this trial is testing

OT SMILE: Occupational Therapy Group Intervention for Primary Brain Tumour Patients

Who this might be right for
Primary Brain TumourGlioblastomaBrain Neoplasms
Royal College of Surgeons, Ireland 96
Not applicableEnded earlyNCT01652768
What this trial is testing

PRESENCE Project: An Early Palliative Care Intervention in Brain Tumors

Who this might be right for
Malignant Brain Tumors
Case Comprehensive Cancer Center 1
Not applicableUnknownNCT02018497
What this trial is testing

Essential Hypotension and Allostasis Registry

Who this might be right for
Blood PressureDepressionPanic Attack+16 more
CES University 5,000
Testing effectiveness (Phase 2)WithdrawnNCT00814593
What this trial is testing

Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery

Who this might be right for
Brain and Central Nervous System Tumors
Lisata Therapeutics, Inc.
Testing effectiveness (Phase 2)Temporarily pausedNCT00003067
What this trial is testing

Biological Therapy in Treating Patients With Primary or Advanced Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Weill Medical College of Cornell University
Not applicableLooking for participantsNCT05622409
What this trial is testing

A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma

Who this might be right for
Primary Malignant Brain Tumors
National Health Research Institutes, Taiwan 250
Testing effectiveness (Phase 2)Study completedNCT02095132
What this trial is testing

Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
Central Nervous System Embryonal Tumor With Rhabdoid FeaturesCentral Nervous System Embryonal Tumor, Not Otherwise SpecifiedCentral Nervous System Ganglioneuroblastoma+12 more
National Cancer Institute (NCI) 76
Testing effectiveness (Phase 2)Study completedNCT00003657
What this trial is testing

High-dose ICE With Amifostine

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsCarcinoma of Unknown Primary+8 more
Dana-Farber Cancer Institute 24
Testing effectiveness (Phase 2)Study completedNCT03650452
What this trial is testing

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

Who this might be right for
EpilepsyDravet SyndromeLennox-Gastaut Syndrome
Takeda 141
Next Page